Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1461-1466

  Vázquez, Beatriz Y Salazar ^a,b   Hightower, C Makena ^a   Martini, Judith ^c   Messmer, Catalina ^a   Frienesenecker, Barbara ^c   Corbels, Pedro ^a   Tsai, Amy G ^a   Intaglietta, Marcos ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

functional capillary density; hemodilution; hydroxyethyl starch; microcirculation; molecular hemoglobin oxygen carrier; shock; survival

Indexed keywords

HEMOGLOBIN GLUTAMER 200; HETASTARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY DIAMETER; ARTICLE; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; EXCHANGE BLOOD TRANSFUSION; HEMODILUTION; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; SURVIVAL;

EID: 79957649090     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182120cdb     Document Type: Article

References (23)

1. Friesenecker BE, Tsai AG, Martini J, et al. Arteriolar vasoconstrictive response: Comparing the effects of arginine vasopressin and norepinephrine. Crit Care 2006; 10:R75.
2. Reah G, Bodenham AR, Mallick A, et al. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997; 25: 1480-1488. (Pubitemid 27391476)
3. Alayash AI: Oxygen therapeutics: Can we tame haemoglobin? Nat Rev Drug Discov 2004; 3:152-159. (Pubitemid 38239776)
4. Stadlbauer KH, Wenzel V, Krismer AC, et al. Vasopressin during uncontrolled hemorrhagic shock: Less bleeding below the diaphragm, more perfusion above. Anesth Analg 2005; 101:830-832. (Pubitemid 41208519)
5. Cabrales P, Tsai AG, Intaglietta M: Microvascular pressure and functional capillary density in extreme hemodilution with low and high plasma viscosity expanders. Am J Physiol 2004; 287:H363-H373. (Pubitemid 38802372)
6. Tsai AG, Friesenecker B, McCarthy M, et al. Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 1998; 275: H2170-H2180.
7. Martini J, Cabrales P, K A, et al. Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEGconjugated human serum albumin than with HES 130/0.4: A microvascular perspective. Crit Care 2008; 12:R54.
8. Endrich B, Asaishi K, Gotz A, et al. Technical report-a new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980; 177:125-134. (Pubitemid 11238699)
9. Friesenecker B, Tsai AG, Instaglietta M: Capillary perfusion during ischemia-reperfusion in subcutaneous connective tissue and skin muscle. Am J Physiol 1994; 267:H2204-H2212.
10. Kerger H, Groth G, Kalenka A, et al. pO(2) measurements by phosphorescence quenching: Characteristics and applications of an automated system. Microvasc Res 2003; 65: 32-38. (Pubitemid 36263288)
11. Winslow RM, Gonzales A, Gonzales ML, et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol 1998; 85:993-1003. (Pubitemid 28413279)
12. Jahr JS, Osgood S, Rothenberg SJ, et al. Lactate measurement interference by hemoglobin- based oxygen carriers (Oxyglobin, Hemopure, and Hemolink). Anesth Analg 2005; 100:431-436. (Pubitemid 40170538)
13. Kerger H, Saltzman DJ, Menger MD, et al. Systemic and subcutaneous microvascular Po2 dissociation during 4-h hemorrhagic shock in conscious hamsters. Am J Physiol 1996; 270:H827-H836.
14. Lindbom L, Tuma RF, Arfors KE: Influence of oxygen on perfused capillary density and capillary red cell velocity in rabbit skeletal muscle. Microvasc Res 1980; 19:197-208. (Pubitemid 10043763)
15. Friesenecker B, Tsai AG, Dü nser MW, et al. Oxygen distribution in microcirculation after arginine vasopressin-induced arteriolar vasoconstriction. Am J Physiol Heart Circ Physiol 2004; 287:H1792-H1800. (Pubitemid 39313288)
16. Cabrales P, Tsai AG, Intaglietta M: Increased tissue pO2 and decreased O2 delivery and consumption after 80% exchange transfusion with polymerized hemoglobin. Am J Physiol 2004; 287:H2825-H2833. (Pubitemid 39557157)
17. Burhop K, Gordon D, Estep T: Review of hemoglobin-induced myocardial lesions. Artif Cells Blood Substit Immobil Biotechnol 2004; 32:353-374. (Pubitemid 39362756)
18. Winslow RM: Alternative oxygen therapeutics: Products, status of clinical trials, and future prospects. Curr Hematol Rep 2003; 2:503-510.
19. Xie YW, Shen W, Zhao G, et al. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res 1996; 79:381-387. (Pubitemid 26276898)
20. Shen W, Xu X, Ochoa M, et al. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994; 75: 1086-1095. (Pubitemid 24351454)
21. Cabrales P, Tsai AG, Intaglietta M: Polymerized bovine hemoglobin can improve small-volume resuscitation from hemorrhagic shock in hamsters. Shock 2009; 31: 300-307.
22. Cabrales P, Tsai AG, Intaglietta M: Isovolemic exchange transfusion with increasing concentrations of low oxygen affinity hemoglobin solution limits oxygen delivery due to vasoconstriction. Am J Physiol Heart Circ Physiol 2008; 295: H2212-H2218.
23. Cabrales P, Tsai AG, Intaglietta M: Balance between vasoconstriction and enhanced oxygen delivery. Transfusion 2008; 48: 2087-2095